Hera - Mi
Hera-MI is a French medtech company that develops Breast-SlimView, a CE-marked AI clinical decision-support software for 2D and 3D mammography using a patented 'negativation' algorithm. It serves radiologists, breast imaging centers, and hospitals across Europe, with US FDA approval in progress.
- Company typePrivate
- Founded2017
- HeadquartersNantes, France
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Hera - Mi does
Hera-MI is a French medical device software company founded in April 2017 by Sylvie Davila (CEO) and Mickael Tardy (Scientific Director), headquartered in Saint-Herblain near Nantes. The company develops Breast-SlimView, a Class IIa CE-marked (notified body KIWA 0476, since November 2019) clinical decision-support software for 2D and 3D mammography (tomosynthesis). Its patented core technology is a 'negativation' deep-learning algorithm that automatically detects and removes physiological breast elements — blood vessels, connective tissue, mammary gland, muscles, and fat — and replaces them with synthetic fat so radiologists see only suspicious areas. A second patent (2022) extends the platform into multimodality correlation across ultrasound, mammography, tomosynthesis, and MRI. The software suite also includes MTE (Mammography Technical Evaluation) for automated image-quality assessment and features breast density evaluation per BIRADS 5th edition, 3-level risk scoring, and prior-examination comparison, all delivered via DICOM-compatible integration into existing PACS infrastructure.
The company monetizes through software licensing and recurring maintenance contracts sold via direct enterprise sales (France, Belgium, Germany, Netherlands) and a network of channel partners and OEM-style integrators including Fujifilm (global), Ethicia (Switzerland/Italy), MODIMEDICARE (India), Viewtech (Mexico), and DRTECH (South Korea), with central purchasing agreements via GAIM, UGAP, and UniHA for French public-sector buyers. Customers are primarily radiologists, breast imaging specialists, and radiographers in hospitals, breast imaging centers, and radiology practices across Europe, North America (planned via Hera-MI Corp., US subsidiary established April 2020), MENA, South Asia, East Asia, and Latin America. FDA approval is in progress to unlock the US market. The company is privately held (SAS form), employs 11-50 staff, and has been commercially active since 2019 with recognized industry positioning (Prix FEMTECH Europe 2024, HUB France IA 2025 laureate).
Hera - Mi firmographics
Firmographics- Name
- Hera - Mi
- Legal name
- Hera-MI
- Website
- https://hera-mi.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Hera-MI is a French medtech company that develops Breast-SlimView, a CE-marked AI clinical decision-support software for 2D and 3D mammography using a patented 'negativation' algorithm. It serves radiologists, breast imaging centers, and hospitals across Europe, with US FDA approval in progress.
- Ownership category
- akta.pro rank
Hera - Mi industry classification
Industry- Product category
- Medical Imaging Software
- NAICS
- Software Publishers (5132), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)
- akta.pro secondary industries
- Medical Imaging AI (HDAAAEAH), Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)
Keywords
Where Hera - Mi is headquartered
LocationHeadquarters
- HQ city
- Nantes
- HQ country
- France
- HQ region
- Europe
Offices4 records
Markets served
Hera - Mi business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Breast-SlimView Software Licenses: Class IIa medical device software sold to radiology centers and hospitals. Installed directly into customer's center infrastructure without requiring additional hardware. Revenue likely generated through software licensing with annual maintenance and support contracts. The company is CE certified and pursuing FDA approval for US market entry.
Go-to-market motion3 records
Distribution channels9 records
Marketing channels8 records
Hera - Mi product offering
Product offeringCore offering
Hera-MI develops and licenses Breast-SlimView, a Class IIa CE-marked medical device software that provides clinical decision support for 2D and 3D mammography (tomosynthesis) interpretation. The software uses a patented 'negativation' AI algorithm that removes physiological breast elements and replaces them with artificial fat to present only suspicious areas to radiologists, complemented by image quality evaluation (MTE), breast density classification, risk scoring, and prior examination comparison. It is sold to radiology departments, breast imaging centers, and hospitals through direct enterprise sales, channel partners, and an OEM integration with Fujifilm mammography equipment.
Product overview
Hera-MI offers the Breast-SlimView Suite as a unified medical device platform for AI-powered mammography analysis. The core Breast-SlimView software provides decision support for 2D and 3D mammography using a patented 'negativation' algorithm, complemented by the MTE (Mammography Technical Evaluation) module for image quality assessment. Features include breast density evaluation based on BIRADS 5th edition, 3-level risk scoring, prior examination comparison, and structured reporting with ultrasound pictogram projection. The company is developing a multimodality correlation feature for integration across imaging modalities.
Differentiator
Problem solved
Functional benefit
Brands
- Breast-SlimView®: Patented clinical decision support software for 2D and 3D mammography and tomosynthesis, designed for breast cancer diagnostic. Features include negativation process, breast density evaluation, risk scoring, and prior examination management.
- Breast-SlimView® Suite
- MTE (Mammography Technical Evaluation)
Products and services
- Breast-SlimView Suite Comprehensive Class IIa CE-marked medical device software suite for clinical decision support in 2D and 3D mammography (tomosynthesis). Includes the patented negativation algorithm, breast density evaluation based on BIRADS 5th edition, 3-level risk scoring, prior examination comparison, structured positioning reports with ultrasound pictograms, and DICOM-compliant integration into the radiologist's standard mammography interface. Sold to radiology departments, breast imaging centers, and hospitals.
- Breast-SlimView Patented decision support software dedicated to 2D and 3D mammography featuring the unique 'negativation' algorithm that detects and removes physiological breast elements and replaces them with artificial fat, displaying only relevant suspicious areas. Assists radiologists in early breast cancer detection. Installed directly into customer center infrastructure without additional hardware.
- MTE (Mammography Technical Evaluation) Image quality assessment module that automatically evaluates mammographic image quality including breast compression, positioning criteria (pectoral, nipple, inframammary fold), and technical artifacts or skin folds. Helps radiographers standardize practices, self-assess positioning, and improve diagnostic reliability.
Quantifiable outcome
- When breast cancer is detected at an early stage, nearly 90% of cases go into remission.
- +2 more outcomes
Companies that use Hera - Mi
Customer profileNamed customers11 records
Segments4 records
Ideal customer profiles3 records
Hera - Mi technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature10 records
Hera - Mi partnerships and signals
Strategic signalPartnerships
19 partnerships are on record, tiered minor and core.
- ASTARTE (Association Transméditerranéenne: Femme et Cancer du Sein)minorPartnership officially announced at SIFEM 2023. Association fighting breast cancer inequalities in screening and treatment. Hera-MI supports awareness campaigns and helps spread messages worldwide.
- TéléDiagcorePartnership with network of 450 radiologists and 143 partner establishments. TéléDiag provides KeyDiag solution and expert radiologist expertise for clinical validation of Hera-MI's 2D & 3D breast imaging AI software.
- AirbuscorePartnership for technological sharing exploration. Signed April 30, 2019 during Airbus delegation visit to Ecole Centrale Nantes. Financial support enables accelerated development through new recruitments and brings international visibility to Hera-MI.
- Fujifilm FrancecoreScientific and business partnership where Fujifilm distributes Breast-SlimView integrated into its mammography equipment. Provides radiologists with clinical decision support tool for 2D/3D mammography interpretation. Distribution in France and overseas markets. 3 workshop sessions held at JFR 2019 on Fujifilm booth.
- LS2N (Laboratoire des Sciences du Numérique de Nantes)coreScientific collaboration with LS2N at Ecole Centrale de Nantes through CIFRE thesis. Mickael Tardy, Scientific Director, conducted thesis under Professor Diana Mateus. Research on AI in medical imaging.
- MEDECOMcoreCommercial partner hosting Hera-MI at ECR congress. Offers MedMammo multimodality diagnostic station that combines with Breast-SlimView for complete French diagnostic solution.
- Ethicia Healthcare ManagementcoreSwiss healthcare management company representing Hera-MI in Switzerland and Italy. Distributes and supports Breast-SlimView installations in these markets.
- French Healthcare AssociationminorAssociation promoting French medical device manufacturers worldwide. Hera-MI featured as member for international visibility.
- PlanmedminorStrategic partnership with major player in 2D/3D mammography with global reach. Planmed mammography systems potentially integrate with Hera-MI AI.
- IDETEC MEDICAL IMAGINGminorFrench company specializing in manufacture and marketing of medical radiology equipment for over 40 years. Leading OEM company in Europe. THALIA mammography systems partner.
- DRTECHminorSouth Korean partner for AIDIA mammography system. World-renowned leader in flat panel mammography and X-ray sensors.
- Viewtech MexicominorMexican distributor specializing in sale, installation, and maintenance of high-tech medical equipment for radiology and mammography. Hera-MI listed on their website.
- MODIMEDICAREminorIndian company commercializing mammography and X-ray equipment. Agent representing Hera-MI mammography AI modules in India with dedicated training services.
- URIEL SRLminorItalian company commercializing and repairing X-ray equipment. Key player based in Italy, close to customers.
- GAIMminorFirst French central purchasing agency in medical imaging. Enables public healthcare institutions to procure Breast-SlimView through established procurement channels.
- UGAPminorOnly generalist public central purchasing agency, 100% dedicated to public purchasing. Enables procurement of Hera-MI solutions by French public sector.
- UniHAminorCooperative of French public hospital buyers. Provides group purchasing options for Breast-SlimView by public hospitals.
- Academic Partners (University of Nantes, University of Rennes, Technical University of Munich, Efrei)coreAcademic partnerships with French and European universities and engineering schools for research collaboration, algorithm development, and talent recruitment.
- Clinical Partners (Hôpitaux universitaires de Strasbourg, Polyclinique Bordeaux Nord, IMBN, RPO, IPADE)coreCollaboration with health institutions and medical imaging centers specializing in senology. Enriches data volume for software learning and provides clinical validation.
Scale indicators4 records
Recent moves7 records
Expansion highlights6 records
Hera - Mi competitors and assessment
Company assessmentDirect peers
- Lunit: South Korea-based publicly listed AI company with Lunit INSIGHT MMG, a mammography AI solution directly comparable to Breast-SlimView in clinical decision support for breast cancer detection. Direct competitor in breast imaging AI across EU, MENA, and Asia.
- Therapixel: French competitor specializing in MammoScreen, an AI-based mammography decision-support tool with CE mark and FDA clearance. Headquartered in France, Therapixel competes most directly with Hera-MI on geography, product, and breast imaging AI category.
- Volpara Health: New Zealand-based breast imaging analytics company offering breast density assessment, mammography reporting, and cancer risk evaluation software. Highly comparable product/clinical positioning in breast imaging AI.
- ScreenPoint Medical: Netherlands-based developer of Transpara, an AI breast imaging decision-support software for 2D/3D mammography with CE mark and FDA clearance. Direct competitor serving the same radiologist and breast center customers.
- iCAD: US-based company offering ProFound AI for breast cancer detection and breast density assessment (PowerDensity), both FDA-cleared. Direct competitor in mammography AI, particularly relevant for Hera-MI's pending US entry.
Emerging players
- DeepHealth (RadNet subsidiary): AI mammography company (Saige-Dx) acquired by RadNet, offering FDA-cleared AI for breast cancer detection and risk prediction. Emerging direct competitor with a strong US distribution backbone via RadNet's imaging centers.
- Densitas: Canada-based company focused on breast density AI and mammography quality analytics, with comparable features to Hera-MI's MTE and breast density evaluation modules. Overlaps at feature level though narrower in overall breadth.
Broad incumbents
- Hologic: US-listed leader in mammography hardware (3Dimensions, Genius AI) and integrated screening workflows. Operates broadly across breast imaging; important OEM-style incumbent that any breast AI specialist must integrate with or compete against.
- Siemens Healthineers: Global medtech incumbent offering mammography systems (Mammomat) and AI-Rad Companion, with broad radiology AI portfolio. Broad incumbent providing integrating opportunities and competitive threats to specialist breast AI vendors.
Others
- Fujifilm Healthcare: Mammography equipment OEM that is both a channel partner and a comparable ecosystem player. Comparable in that it sits adjacent as a mammography hardware vendor with breast imaging AI integrations, including Hera-MI's Breast-SlimView.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Hera - Mi social profiles
Digital presenceHera - Mi compliance and trust
Trust signalCompliance2 records
Hera - Mi financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hera - Mi leadership team
Management profileNumber of profiles
Profiles9 records
Hera - Mi subsidiaries and ownership
Company hierarchySubsidiaries1 record
Hera - Mi funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hera - Mi M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hera - Mi
What does Hera - Mi do?
Hera-MI develops and licenses Breast-SlimView, a Class IIa CE-marked medical device software that provides clinical decision support for 2D and 3D mammography (tomosynthesis) interpretation. The software uses a patented 'negativation' AI algorithm that removes physiological breast elements and replaces them with artificial fat to present only suspicious areas to radiologists, complemented by image quality evaluation (MTE), breast density classification, risk scoring, and prior examination comparison. It is sold to radiology departments, breast imaging centers, and hospitals through direct enterprise sales, channel partners, and an OEM integration with Fujifilm mammography equipment.
Is Hera - Mi a public or private company?
Hera - Mi is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Hera - Mi founded?
Hera - Mi was founded in 2017. It employs 11 to 50 people.
Where is Hera - Mi based?
Hera - Mi is headquartered in Nantes, France, in the Europe region.
How does Hera - Mi make money?
One revenue line is on record: breast-SlimView Software Licenses.
Who are Hera - Mi's main competitors?
Direct peers on record are Lunit, Therapixel, Volpara Health, ScreenPoint Medical and iCAD. Emerging players are DeepHealth (RadNet subsidiary) and Densitas. Broad incumbents are Hologic and Siemens Healthineers. Fujifilm Healthcare is listed as an others.
Does Hera - Mi have an API?
No public API is recorded for Hera - Mi.
What industry is Hera - Mi in?
Hera - Mi's product category is Medical Imaging Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 5132 and its SIC code is 3841.